Detalles de la búsqueda
1.
A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer.
Int J Cancer
; 138(1): 195-205, 2016 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26152787
2.
Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model.
Int J Cancer
; 136(8): 1967-75, 2015 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25242168
3.
A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma.
Invest New Drugs
; 32(4): 739-45, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24668033
4.
Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancer.
Invest New Drugs
; 31(2): 345-54, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22615057
5.
Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models.
Clin Cancer Drugs
; 5(1): 42-49, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30631747
6.
Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms.
Mol Cancer Ther
; 17(10): 2112-2122, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30026382
7.
Regression of a Fungating Tumor After Hypofractionated Radiation Therapy in a Patient With Metastatic Breast Cancer.
Cureus
; 9(7): e1417, 2017 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28875090
8.
Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model.
PLoS One
; 12(11): e0187173, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29091939
9.
The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapy.
Oncotarget
; 8(67): 110904-110913, 2017 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29340025
10.
Aldehyde Dehydrogenase 1B1 as a Modulator of Pancreatic Adenocarcinoma.
Pancreas
; 45(1): 117-22, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26566217
11.
The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance.
Oncotarget
; 7(19): 28273-85, 2016 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27070088
12.
Biomarker-driven trial in metastatic pancreas cancer: feasibility in a multicenter study of saracatinib, an oral Src inhibitor, in previously treated pancreatic cancer.
Cancer Med
; 1(2): 207-17, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23342270
13.
Common PIK3CA mutants and a novel 3' UTR mutation are associated with increased sensitivity to saracatinib.
Clin Cancer Res
; 18(9): 2704-14, 2012 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22553375
14.
ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer.
Mol Oncol
; 6(3): 370-81, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22521243
Resultados
1 -
14
de 14
1
Próxima >
>>